- Home
- CVAC vs PGRE Comparison
CVAC vs PGRE Comparison
Compare CVAC & PGRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CVAC | PGRE |
|---|---|---|
| Founded | 2000 | 1978 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.5B |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CVAC | PGRE |
|---|---|---|
| Price | $5.17 | $6.59 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 5 |
| Target Price | ★ $6.83 | $6.80 |
| AVG Volume (30 Days) | ★ 1.6M | 1.3M |
| Earning Date | 11-24-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 94.02 | N/A |
| EPS | ★ 0.94 | N/A |
| Revenue | $83,000,117.00 | ★ $681,644,000.00 |
| Revenue This Year | N/A | $1.86 |
| Revenue Next Year | $23.40 | $1.08 |
| P/E Ratio | $5.51 | ★ N/A |
| Revenue Growth | N/A | ★ 23.12 |
| 52 Week Low | $2.48 | $3.75 |
| 52 Week High | $5.72 | $7.85 |
Technical Indicators
Market Signals| Indicator | CVAC | PGRE |
|---|---|---|
| Relative Strength Index (RSI) | 44.01 | 55.69 |
| Support Level | $5.11 | $6.54 |
| Resistance Level | $5.55 | $6.58 |
| Average True Range (ATR) | 0.12 | 0.02 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 35.00 | 90.00 |
Price Performance
Historical ComparisonAbout CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About PGRE Paramount Group Inc.
Paramount Group Inc is a real estate investment trust engaged in owning, operating, managing, acquiring, and redeveloping high-quality, Class A office properties in select central business district (CBD) submarkets of New York City and San Francisco. The company operates in two geographical segments New York and San Francisco. The company derives nearly all of its majority of revenue from rental income.